FR2829149B1 - Souche neurovirulente du virus west nile et ses applications - Google Patents

Souche neurovirulente du virus west nile et ses applications

Info

Publication number
FR2829149B1
FR2829149B1 FR0111525A FR0111525A FR2829149B1 FR 2829149 B1 FR2829149 B1 FR 2829149B1 FR 0111525 A FR0111525 A FR 0111525A FR 0111525 A FR0111525 A FR 0111525A FR 2829149 B1 FR2829149 B1 FR 2829149B1
Authority
FR
France
Prior art keywords
applications
west nile
nile virus
neurovirulent strain
neurovirulent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0111525A
Other languages
English (en)
Other versions
FR2829149A1 (fr
Inventor
Philippe Despres
Vincent Deubel
Jean Louis Guenet
Marie Therese Drouet
Mertyn Malkinson
Caroline Banet
Marie Pascale Frenkiel
Marie Pierre Courageot
Fasseli Coulibaly
Adeline Catteau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0111525A priority Critical patent/FR2829149B1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to DE60231970T priority patent/DE60231970D1/de
Priority to DK02759815T priority patent/DK1383796T3/da
Priority to ES02759815T priority patent/ES2327217T5/es
Priority to PT02759815T priority patent/PT1383796E/pt
Priority to CA2443290A priority patent/CA2443290C/fr
Priority to PCT/FR2002/001168 priority patent/WO2002081511A1/fr
Priority to AT02759815T priority patent/ATE428725T1/de
Priority to EP02759815A priority patent/EP1383796B2/fr
Publication of FR2829149A1 publication Critical patent/FR2829149A1/fr
Application granted granted Critical
Publication of FR2829149B1 publication Critical patent/FR2829149B1/fr
Priority to US10/956,085 priority patent/US7390495B2/en
Priority to US12/112,366 priority patent/US20100099854A1/en
Priority to CY20091100749T priority patent/CY1109244T1/el
Priority to US13/423,161 priority patent/US8715693B2/en
Priority to US14/230,776 priority patent/US9657276B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR0111525A 2001-04-04 2001-09-06 Souche neurovirulente du virus west nile et ses applications Expired - Fee Related FR2829149B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR0111525A FR2829149B1 (fr) 2001-09-06 2001-09-06 Souche neurovirulente du virus west nile et ses applications
EP02759815A EP1383796B2 (fr) 2001-04-04 2002-04-04 Souche neurovirulente du virus west-nile et ses applications
DK02759815T DK1383796T3 (da) 2001-04-04 2002-04-04 Neurovirulent stamme af viruset West Nile og anvendelser heraf
ES02759815T ES2327217T5 (es) 2001-04-04 2002-04-04 Cepa neurovirulenta del virus West-Nile y sus aplicaciones
PT02759815T PT1383796E (pt) 2001-04-04 2002-04-04 Estirpe neurovirulenta do vírus do nilo ocidental e as suas aplicações
CA2443290A CA2443290C (fr) 2001-04-04 2002-04-04 Souche neurovirulente du virus west-nile et ses applications
PCT/FR2002/001168 WO2002081511A1 (fr) 2001-04-04 2002-04-04 Souche neurovirulente du virus west-nile et ses applications
AT02759815T ATE428725T1 (de) 2001-04-04 2002-04-04 Neurovirulenter stamm des west-nile-virus und anwendungen davon
DE60231970T DE60231970D1 (de) 2001-04-04 2002-04-04 Neurovirulenter stamm des west-nile-virus und anwendungen davon
US10/956,085 US7390495B2 (en) 2001-04-04 2004-10-04 Neurovirulent strain of the West Nile virus and uses thereof
US12/112,366 US20100099854A1 (en) 2001-04-04 2008-04-30 Neurovirulent strain of the west nile virus and uses thereof
CY20091100749T CY1109244T1 (el) 2001-04-04 2009-07-14 Νευρολοιμογονο στελεχος του ιου δυτικου νειλου και εφαρμογες αυτου.
US13/423,161 US8715693B2 (en) 2001-04-04 2012-03-16 Neurovirulent strain of the West Nile virus and uses thereof
US14/230,776 US9657276B2 (en) 2001-04-04 2014-03-31 Neurovirulent strain of the West Nile virus and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0111525A FR2829149B1 (fr) 2001-09-06 2001-09-06 Souche neurovirulente du virus west nile et ses applications

Publications (2)

Publication Number Publication Date
FR2829149A1 FR2829149A1 (fr) 2003-03-07
FR2829149B1 true FR2829149B1 (fr) 2004-09-24

Family

ID=8867020

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0111525A Expired - Fee Related FR2829149B1 (fr) 2001-04-04 2001-09-06 Souche neurovirulente du virus west nile et ses applications

Country Status (1)

Country Link
FR (1) FR2829149B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4912151B2 (ja) * 2003-11-12 2012-04-11 バイエル・ヘルスケア・エルエルシー 西ナイルウイルスを検出するためのオリゴヌクレオチドおよび方法
RU2595429C1 (ru) * 2015-04-21 2016-08-27 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") ШТАММ ГИБРИДНЫХ КЛЕТОК ЖИВОТНОГО Mus musculus L. 5Н6 - ПРОДУЦЕНТ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ДЛЯ ВЫЯВЛЕНИЯ ГЛИКОПРОТЕИНА Е ВИРУСА ЗАПАДНОГО НИЛА, МОНОКЛОНАЛЬНЫЕ АНТИТЕЛА 5Н6, ПРОДУЦИРУЕМЫЕ УКАЗАННЫМ ШТАММОМ ГИБРИДНЫХ КЛЕТОК, И ИММУНОФЕРМЕНТНЫЙ НАБОР ДЛЯ ВЫЯВЛЕНИЯ ГЛИКОПРОТЕИНА Е ВИРУСА ЗАПАДНОГО НИЛА С ИСПОЛЬЗОВАНИЕМ УКАЗАННЫХ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2311395C (fr) * 1997-11-28 2006-11-28 Replikun Biotech Pty Ltd Systeme d'expression et de diffusion propre au flavivirus

Also Published As

Publication number Publication date
FR2829149A1 (fr) 2003-03-07

Similar Documents

Publication Publication Date Title
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DK1397492T3 (da) Modificerede og stabiliserede GDF-propeptider og deres anvendelser
CY2016018I1 (el) Εμβολιο κατα του ιου του δυτικου νειλου
EP1509233A4 (fr) Preparation liquide de decitabine et ses utilisations
ITRM20020615A1 (it) Dispositivo di regolazione di inclinazione e incidenza di una
CY2014010I2 (el) Εμβολιο δυτικου νειλου
DE60227300D1 (de) Strukturen von anschlusselementen und anzuschliessende komponente
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
EP1545599A4 (fr) Compositions immunogenes et utilisations diagnostiques et therapeutiques de celles-ci
NO20034212L (no) Kvartsglasskomponent og fremstilling derav
NO20034405L (no) Anti-ostepontin-antistoff og anvendelse derav
DE60220479D1 (de) Poloxymethylencopolymer und daraus hergestelltes formteil
IL179874A0 (en) Antibodies against west nile virus and therapeutic and prophylactic uses thereof
EP1370884A4 (fr) Circuit echantillonneur-bloqueur transpinoriel et applications associees
EP1392106A4 (fr) Genes tyra et utilisations associees
NO20042692L (no) Sementakselerator og fremgangsmate
DK2116257T3 (da) Parenterale vaccineformuleringer og anvendelser deraf
AU2002305028A1 (en) West nile virus epitopes and uses thereof
NO20042693L (no) Kateterpreparat og anvendelser derav
FR2823218B1 (fr) Souche neurovirulente du virus west nile et ses applications
FR2829149B1 (fr) Souche neurovirulente du virus west nile et ses applications
ITMI20001897A0 (it) Miscele di elastomeri fluorurati ed acrilici
EP1446130A4 (fr) Genes extrait de ehrlichia canis et vaccins contre cette bacterie
EP1407039A4 (fr) Vaccins de vecteur anti-arthropode et techniques de selection et d'utilisations de ceux-ci

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130531